Navigation Links
Large Controlled Trial of Widely Used Mood Stabilizers Demonstrates Efficacy in Pediatric Bipolar Disorder
Date:10/26/2007

n's ranks second among all pediatric institutions in the United States in grants from the National Institutes of Health. It has an established tradition of research excellence, with discoveries including the Sabin oral polio vaccine, the surfactant preparation that saves the lives of thousands of premature infants each year, and a rotavirus vaccine that saves the lives of hundreds of thousands of infants around the world each year. Current strategic directions include the translation of basic laboratory research into the development of novel therapeutics for the treatment of disease, and furthering the development of personalized and predictive medicine. Additional information can be found at http://www.cincinnatichildrens.org.


'/>"/>
SOURCE Cincinnati Children's Hospital Medical Center
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Urinalysis Analyzers: Large Capabilities in Every Size Device
2. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
5. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
6. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
7. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
8. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
9. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...rPACSandEMR ,, http://www.reportlinker.com/p...=prnewswire&utm_medium=pr&utm_campaign=prn...atalmost$1.3billion,representinganincreaseof6.7%ov...s),mediumhospitals(201-499beds),communityhospitals...
(Date:11/23/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...nSystems&Equipment-AGlobalMarketPerspective ,...ization-Systems--Equipment---A-Global-Market-Persp...r&utm_campaign=prnewswire ,, Steamsteri...procedure.Steamsterilizationmarketisstableduetoreg...
(Date:11/23/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...sposables-AWorldMarketReview ,, http://www.r...A-World-Market-Review.html#utm_source=prnewswire&a..., Globalgeneralanesthesiadisposablesmarketischa...iderablerisewitnessedingeneralsurgicalprocedures,g...
Breaking Medicine Technology:Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Young Innovations Inc Provides Second Quarter Conference Call Details 51838 1Young Innovations Inc Provides Second Quarter Conference Call Details 51838 2Narconon of Georgia Saves Lives of Orphaned Children in Honduras 51834 1Narconon of Georgia Saves Lives of Orphaned Children in Honduras 51834 2New Map of Genomic Variation Will Enable Disease Research 51829 1New Map of Genomic Variation Will Enable Disease Research 51829 2New Map of Genomic Variation Will Enable Disease Research 51829 3New Map of Genomic Variation Will Enable Disease Research 51829 4
...e for PEGINTRON(TM) and REBETOL(R) offers certain ...ess , , KENILWORTH, N.J., March 11 Schering-Plou... the U.S. Food and Drug Administration (FDA) has a...ron alfa-2b) and REBETOL(R) (ribavirin, USP) combi... patients 3 years of age and older with compensate...
...F PRUSSIA, Pa., March 11 CSL Behring has been inf...A) that because RiaSTAP(TM) is the first FDA-appro...ts with congenital fibrinogen deficiency, the comp...usivity. RiaSTAP was approved by the FDA in Janua...eding episodes in patients with congenital fibrino...
Other Medicine Technology:FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 2FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 3FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 4FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 5FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 6FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 7FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 8FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C 9CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency 2CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency 3CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency 4
(Date:11/24/2009)... Frozen Shoulder experts offer seminar series, new...rgical relief to millions of sufferers. , ...009 -- One-To-Zero (OTZ) Health Education Systems ...2010 Frozen Shoulder Syndrome Diagnosis & Tre... seminars begin at noon Friday and end at noon Sun...
(Date:11/24/2009)...RNewswire-FirstCall/--USFarms,Inc.,(PinkSheets:USF...productsispleasedtoannounceithasreceivedformalcert...n(AVA)foritsAloe365(TM)Juiceproduct. ,, YanSkwa...uncethatwehavecompletedthecertificationprocesswith...5(TM)Juice.TheprimarygoaloftheAVAistoprovideawidel...
(Date:11/24/2009)...,S-1RegistrationStatementbeingPreparedbyLeadingLaw....,Nov.24/PRNewswire-FirstCall/--AmericanScientific...sedtomakeavailableacurrentcorporateupdate. ,, S...recently,ASRhasbeendiligentinaccomplishingaddition...heCompany. ,, Aspartofthisongoingprocess,2009th...
(Date:11/24/2009)...,Nov.24/PRNewswire-USNewswire/--Thefollowingshould...eW.K.KelloggFoundation: ,, TheW.K.KelloggFounda...edtocomprehensivelyandsubstantiallystrengthenoralh...ecently,theSenateversionofhealthreformrepresentsah...wodozenimportantprovisionsaimedatimprovingoralheal...
(Date:11/24/2009)...s behind reasoning that testing less is OK , ...rld of cancer screening has been upended in the pa...e Services Task Force (USPSTF) just raise the age ...gram from 40 to 50, but the American College of Ob...lescents should be spared the inconvenience and po...
Breaking Medicine News(10 mins):Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:US Farms, Inc. Receives American Vegetarian Association Certification Approval for Aloe365(TM) Juice Product 2Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3Health News:Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform 2Health News:Recent Cancer Screening Changes Leave Many Confused 2Health News:Recent Cancer Screening Changes Leave Many Confused 3Health News:Recent Cancer Screening Changes Leave Many Confused 4
...f its kind finds no health downside to donation , ...mericans who give the gift of life by donating a k... , That,s the conclusion of the largest, longest f...san N. Ibrahim, an associate professor of medicine...
....Y., Jan. 28 NBTY, Inc. (NYSE: NTY ) ( www.NBTY... of nutritional supplements, today announced resul... 2008. , , For the fiscal first quarter ended Dec... or 29%. Included in this total are net sales fro...
...signed and evaluated at The Medical College of Wis...isk populations has been one of eight chosen by th..., for inclusion in The 2008 Compendium of Evidence...fer behaviors. , The program known as Popular O...
, EAST RUTHERFORD, N.J., Jan. 28 CCA Industries, Inc. (NYSE ALTERNEXT US: CAW) announced today that the Board of Directors declared a $.11 per share dividend for the 1st Quarter ending February 28,
...J., Jan. 28 Covance Inc. (NYSE: CVD ) today rep...er 31, 2008 of $0.72 per diluted share. For the f...year-on-year from $2.71 in 2007. Excluding the ga...sly announced, reduced demand in our Early Develop...
... Jan. 28 Leading Philadelphia lawyer Robert Spine...and noted Texas attorney Aaron DeLuca of DeLuca &a... and medical education for attorneys featuring doc...Specific Causation Evidence in Toxic Tort Cases" w...
Other Medicine News:Health News:Most Kidney Donors Lead Long, Healthy Lives 2Health News:Most Kidney Donors Lead Long, Healthy Lives 3Health News:NBTY Reports First Quarter Results 2Health News:NBTY Reports First Quarter Results 3Health News:NBTY Reports First Quarter Results 4Health News:NBTY Reports First Quarter Results 5Health News:NBTY Reports First Quarter Results 6Health News:NBTY Reports First Quarter Results 7Health News:NBTY Reports First Quarter Results 8Health News:NBTY Reports First Quarter Results 9Health News:NBTY Reports First Quarter Results 10Health News:NBTY Reports First Quarter Results 11Health News:NBTY Reports First Quarter Results 12Health News:NBTY Reports First Quarter Results 13Health News:NBTY Reports First Quarter Results 14Health News:NBTY Reports First Quarter Results 15Health News:NBTY Reports First Quarter Results 16Health News:Medical College of Wisconsin recognized for AIDS intervention research 2Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 2Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 3Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 4Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 5Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 6Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 7Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 8Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 9Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 10Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 11Health News:Covance Reports Fourth Quarter and Full-Year 2008 Results 12Health News:Toxic Causation Training Day for Attorneys 2
...Evaluation and Management guidelines in selecting ...nformation, it calculates the HCFA scores for each... of changing different parts of the exam. ZapCode ...ate an audit trail of your exam. It can print this...
MD Coder v6.0
MedCalc 3000
mobileMICROMEDE™
Medicine Products: